Business Wire

Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.

The latest release of Aspyra’s AccessNET PACS (Picture Archive Communication System), version 6.5.0 includes the IHE compliant hanging protocols and display capabilities for digital mammography studies (pending 510(k) clearance). Other enhancements in AccessNET PACS v6.5 target performance improvement for accessing and reading radiological images. This includes more intelligent compression for transferring images and dictation from remote locations and improvements in the navigation and functionality of commonly used imaging tools; management of hang protocols and window / level presets on a system level as well as user preference; the use of existing hang profiles for closely related display configurations if the specific configuration is not available; and the use on-board functionality of the Matrox Xenia card for much improved real-time image processing.

Bill Culton, Aspyra’s Diagnostic Solutions Product Manager, states, “By building one general workstation which can be used to read all study types, the need for dedicated reading workstations is eliminated.” He continued, “This reduces additional costs associated with multiple workstations that are often required to read different study types.”

About Aspyra

Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, visit www.aspyra.com.

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra’s markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of today the date of this press release, including management's own knowledge and assessment of the Company’s industry and competition. Factors that could cause Aspyra’s actual results to differ materially from these forward-looking statements include among others: the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.